← back to search

Xiangdong Li

Zhejiang University · CN
Area of research
Cancer Research · Surgery
Research interest
Research interests include Cancer-related molecular mechanisms research, Bladder and Urothelial Cancer Treatments, Reproductive Biology and Fertility, and MicroRNA in disease regulation.
h-index
44
citations
7,232
works
301
NIH funding
primary concept
Medicine
email

Recent publications

eIF3f promotes tumour malignancy by remodelling fatty acid biosynthesis in hepatocellular carcinoma
Journal of Hepatology 2025cited by 20position: middledoi
Isolation and pathogenicity of a novel recombinant pseudorabies virus from the attenuated vaccine and classical strains
Frontiers in Veterinary Science 2025cited by 3position: lastdoi
CircSMEK1 Suppresses HCC via the hnRNPK-IGF2-AKT Axis: A Diagnostic Biomarker and Therapeutic Target.
2025cited by 2position: contributordoi
miR-423-3p inhibits CTNNBIP1/WNT preventing hyperandrogenic polycystic ovary syndrome†.
2025cited by 1position: contributordoi
Liquid-liquid phase separation of ATXN2L enhances mRNA translation in hepatocellular carcinoma.
2025cited by 0position: contributordoi
Circular RNA CLASP1 modulates the GLI1/SNAIL axis and enhances macrophage polarization in breast cancer.
2025cited by 0position: contributordoi
Novel ectopic expression of zona pellucida 3 glycoprotein in lung cancer promotes tumor growth
International Journal of Cancer 2024cited by 5position: middledoi
Novel ectopic expression of zona pellucida 3 glycoprotein in lung cancer promotes tumor growth.
2024cited by 4position: contributordoi
A novel polypeptide encoded by the circular RNA ZKSCAN1 suppresses HCC via degradation of mTOR.
2023cited by 106position: contributordoi
m5C-dependent cross-regulation between nuclear reader ALYREF and writer NSUN2 promotes urothelial bladder cancer malignancy through facilitating RABL6/TK1 mRNAs splicing and stabilization
Cell Death and Disease 2023cited by 92position: middledoi
A novel polypeptide CAPG-171aa encoded by circCAPG plays a critical role in triple-negative breast cancer.
2023cited by 43position: contributordoi
G3BP1 and SLU7 Jointly Promote Immune Evasion by Downregulating MHC‐I via PI3K/Akt Activation in Bladder Cancer
Advanced Science 2023cited by 29position: middledoi
Role and mechanism of miR-335-5p in the pathogenesis and treatment of polycystic ovary syndrome.
2023cited by 22position: contributordoi
The molecular mechanism of miR-96-5p in the pathogenesis and treatment of polycystic ovary syndrome.
2023cited by 17position: contributordoi
Interferon-dependent SLC14A1+ cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer
Cancer Cell 2022cited by 230position: middledoi
circMRPS35 promotes malignant progression and cisplatin resistance in hepatocellular carcinoma.
2022cited by 81position: contributordoi
Nucleolar protein NOC4L inhibits tumorigenesis and progression by attenuating SIRT1-mediated p53 deacetylation.
2022cited by 12position: contributordoi
Novel expression of zona pellucida 3 protein in normal testis; potential functional implications.
2022cited by 9position: contributordoi
Deletion of Letmd1 leads to the disruption of mitochondrial function in brown adipose tissue.
2022cited by 6position: contributordoi
Adtrp regulates thermogenic activity of adipose tissue via mediating the secretion of S100b.
2022cited by 5position: contributordoi
Application and outlook of topical hemostatic materials: a narrative review.
2021cited by 71position: contributordoi
LRPPRC regulates redox homeostasis via the circANKHD1/FOXM1 axis to enhance bladder urothelial carcinoma tumorigenesis
Redox Biology 2021cited by 67position: middledoi
Cannabidiol attenuates pulmonary arterial hypertension by improving vascular smooth muscle cells mitochondrial function.
2021cited by 45position: contributordoi
lncRNA MEG3 inhibits pituitary tumor development by participating in cell proliferation, apoptosis and EMT processes
Oncology Reports 2021cited by 23position: middledoi
Macrophage deletion of Noc4l triggers endosomal TLR4/TRIF signal and leads to insulin resistance.
2021cited by 11position: contributordoi
SlSNAT Interacts with HSP40, a Molecular Chaperone, to Regulate Melatonin Biosynthesis and Promote Thermotolerance in Tomato.
2020cited by 53position: contributordoi
Melatonin inhibits inflammasome-associated activation of endothelium and macrophages attenuating pulmonary arterial hypertension.
2020cited by 43position: contributordoi
MicroRNA-487a-3p functions as a new tumor suppressor in prostate cancer by targeting CCND1.
2020cited by 26position: contributordoi
Serum amyloid A exhibits pH dependent antibacterial action and contributes to host defense against <i>Staphylococcus aureus</i> cutaneous infection.
2020cited by 22position: contributordoi
Oncogenic Network and Hub Genes for Natural Killer/T-Cell Lymphoma Utilizing WGCNA.
2020cited by 18position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Nafis A. Rahman · Medical University of Białystok15 papers (2019–2025) · 6 papers (2020–2025)Zhuowei Liu · Xiangya Hospital Central South University5 papers (2017–2023)Jorma Toppari · University of Turku3 papers (2020–2024) · 2 papers (2020–2024)Piotr Bernaczyk · Medical University of Białystok2 papers (2020–2024)Pei Dong · Sun Yat-sen University2 papers (2017–2021)Fangjian Zhou · Tongji University2 papers (2017–2023)Kai Yao · Sun Yat-sen University2 papers (2017–2021)Zhaohui Zhou · Sun Yat-sen University2 papers (2023–2023)Wenqiang Ma · Nanjing Agricultural University2 papers (2016–2016)Jun Zhao · Nanchang University2 papers (2012–2012)Yulu Peng · Sun Yat-sen University2 papers (2021–2023)Yunlin Ye · Sun Yat-sen University2 papers (2021–2023)Ning Wang · Sheffield Hallam University2 papers (2021–2023)Yong Zhang · Nanjing University of Chinese Medicine1 papers (2016–2016)Zhenhua Liu · Ganzhou People's Hospital1 papers (2021–2021)Zhenhua Liu · Shandong University of Traditional Chinese Medicine1 papers (2023–2023)Kui Zhang · Southwest University1 papers (2012–2012)Ting Chen · Centre National de la Recherche Scientifique1 papers (2025–2025)